Orphan designation: amatuximab Treatment of malignant mesothelioma, 16/01/2014 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 21 August 2026 - 13:18

Orphan designation: amatuximab Treatment of malignant mesothelioma, 16/01/2014 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-13-1222

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters